Search

Your search keyword '"Gregorini G"' showing total 350 results
Start Over Author "Gregorini G"
350 results on '"Gregorini G"'

51. Prefazione

Author

Anni R, Gregorini G, Pasini MP, Taccolini, Mario, Taccolini Mario (ORCID:0000-0002-5687-2778), Anni R, Gregorini G, Pasini MP, Taccolini, Mario, and Taccolini Mario (ORCID:0000-0002-5687-2778)

Abstract

Il volume raccoglie saggi sulla storia degli Alleati a Brescia tra guerra e ricostruzione.

Published
2018

52. Presentazione

Author

Maffi, L, Rochini , M, Gregorini, G, Taccolini, Mario, Mario Taccolini (ORCID:0000-0002-5687-2778), Maffi, L, Rochini , M, Gregorini, G, Taccolini, Mario, and Mario Taccolini (ORCID:0000-0002-5687-2778)

Abstract

Il volume analizza i sistemi del dare nelle diverse aree regionali italiane nel XVIII secolo.

Published
2018

53. Disuguaglianze economiche e salute nell’Italia contemporanea

Author

Università Cattolica del Sacro Cuore, Società italiana degli Storici economici, Gregorini, G, Fumi, Gianpiero, Fumi, G (ORCID:0000-0002-8107-3505), Università Cattolica del Sacro Cuore, Società italiana degli Storici economici, Gregorini, G, Fumi, Gianpiero, and Fumi, G (ORCID:0000-0002-8107-3505)

Abstract

La 'rivoluzione della salute' dell’ultimo secolo ha avuto forti conseguenze sulla società e sull'economia. L'ambito sanitario svolge infatti un ruolo cruciale negli equilibri sociali, incide su riproduzione e consumo, regge un’importante filiera della salute, è in prima fila nella ricerca scientifica e tecnologica. Di qui l’importanza di considerare le performance sanitarie anche alla luce della categoria uguaglianza/diseguaglianza (senza ignorare la difficoltà di definire cosa siano le “diseguaglianze” nella salute personale e soprattutto quali ne siano le cause). Le crescenti aspettative dei cittadini sono il riflesso dell’oggettivo miglioramento delle condizioni socio-sanitarie in Italia dall’unità ad oggi e della riduzione dei divari nei principali parametri di salute (speranza di vita, mortalità infantile, cause di morbilità, ecc.) tra generi, classi d’età, aree geografiche, ceti sociali. L’evidenza empirica rivela dunque i notevoli progressi di lungo periodo che hanno portato l’Italia nelle posizioni di testa della classifica mondiale dei principali indicatori sanitari. Tuttavia, ancora a un secolo dall'unificazione si registravano significative differenze nei servizi per la salute, differenze di cui il saggio indaga le cause. Ciò aprì la strada a una radicale riforma con l’introduzione del Servizio sanitario nazionale negli anni Settanta., The 'health revolution’ of the last century has had major consequences on population and economy; and not just today the healthcare sector plays a crucial role in the social equilibrium, shaping reproduction and consumption behaviors, represents an important supply chain and is at the forefront of the scientific and technological research. Hence the importance of considering the health performances also in the light of the category ‘equality / inequality’ (without ignoring the difficulty of defining what ‘health inequalitiy’ is and which are its causes). Regarding Italy from the Unification up to the present, the increased expectations of citizens reflect the real improvements of the social and health conditions and also the reduction of the gaps in the main health parameters (life expectancy, infant mortality, causes of morbidity, etc.) between geographical areas, social classes, genres, and different ages. The empirical evidence thus reveals the considerable long-term progress that has led Italy to the top positions of the world ranking of the main health indicators. But still a century after Unification there were significant occupational and geographical differences in health services, whose causes the essay investigates. This paved the way for a radical reform established with the introduction of the National Health Service in the 1970s.

Published
2018

60. ANCA-associated vasculitis in childhood: Recent advances

Author

Calatroni, M, Oliva, E, Gianfreda, D, Gregorini, G, Allinovi, M, Ramirez, G, Bozzolo, E, Monti, S, Bracaglia, C, Marucci, G, Bodria, M, Sinico, R, Pieruzzi, F, Moroni, G, Pastore, S, Emmi, G, Esposito, P, Catanoso, M, Barbano, G, Bonanni, A, Vaglio, A, Sinico, RA, Pieruzzi, FUEG, Vaglio, A., Calatroni, M, Oliva, E, Gianfreda, D, Gregorini, G, Allinovi, M, Ramirez, G, Bozzolo, E, Monti, S, Bracaglia, C, Marucci, G, Bodria, M, Sinico, R, Pieruzzi, F, Moroni, G, Pastore, S, Emmi, G, Esposito, P, Catanoso, M, Barbano, G, Bonanni, A, Vaglio, A, Sinico, RA, Pieruzzi, FUEG, and Vaglio, A.

Abstract

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are rare systemic diseases that usually occur in adulthood. They comprise granulomatosis with polyangiitis (GPA, Wegener's), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome). Their clinical presentation is often heterogeneous, with frequent involvement of the respiratory tract, the kidney, the skin and the joints. ANCA-associated vasculitis is rare in childhood but North-American and European cohort studies performed during the last decade have clarified their phenotype, patterns of renal involvement and their prognostic implications, and outcome. Herein, we review the main clinical and therapeutic aspects of childhood-onset ANCA-associated vasculitis, and provide preliminary data on demographic characteristics and organ manifestations of an Italian multicentre cohort.

Published
2017

61. Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis

Author

Alberici, F, Smith, R, Fonseca, M, Willcocks, L, Jones, R, Holle, J, Wieczorek, S, Neumann, T, Martorana, D, Gregorini, G, Sinico, R, Bruchfeld, A, Gunnarsson, I, Ohlsson, S, Baslund, B, Tesar, V, Hruskova, Z, Cid, M, Vaglio, A, Lyons, P, Smith, K, Jayne, D, Jayne, D., SINICO, RENATO ALBERTO, Alberici, F, Smith, R, Fonseca, M, Willcocks, L, Jones, R, Holle, J, Wieczorek, S, Neumann, T, Martorana, D, Gregorini, G, Sinico, R, Bruchfeld, A, Gunnarsson, I, Ohlsson, S, Baslund, B, Tesar, V, Hruskova, Z, Cid, M, Vaglio, A, Lyons, P, Smith, K, Jayne, D, Jayne, D., and SINICO, RENATO ALBERTO

Published
2017

62. Economic and Financial Management of Religious Congregations in Late Modern Italy

Author

Gregorini, G, Semeraro, Riccardo, Semeraro, R (ORCID:0000-0003-4181-1064), Gregorini, G, Semeraro, Riccardo, and Semeraro, R (ORCID:0000-0003-4181-1064)

Abstract

As well described by Giancarlo Rocca, nowadays, the Italian historiography regarding religious congregations can count on a large number of scientific publications and different lines of research. This paper reviews the existing literature to outline the development and characterizing features of religious congregations’ financial administration: the goal is to highlight patterns and turning points on the basis of several case studies developed by well-known Italian historians.

Published
2017

63. Preface

Author

Gregorini, G, Taccolini, Mario, Taccolini, M. (ORCID:0000-0002-5687-2778), Gregorini, G, Taccolini, Mario, and Taccolini, M. (ORCID:0000-0002-5687-2778)

Abstract

Prefazione al volume che tratta di Teresa Verzeri e delle congregazioni religiose nell'Europa moderna.

Published
2017

64. Annotazioni letterarie sull'assistenza ai feriti della II Guerra d'Indipendenza

Author

Tettamanzi, G, Fappani, A, Cipolla, C, Ganzerla, G, Taccolini, M, Gregorini, G, Onger, S, Porro, A, Dusi, A, Corsini, P, Zane, M, Trebeschi, M, Sposetti, P, Fabbri, A, David, C, Giuliano, L, Dusi, P, Benedetti, C, Nichilo, V, Boroni, C, Balboni, M, Vanni, D, Vanni, P, Cipolla,C, Corsini,P, Boroni, Carla, Boroni, Carla (ORCID:0000-0003-0549-3361), Tettamanzi, G, Fappani, A, Cipolla, C, Ganzerla, G, Taccolini, M, Gregorini, G, Onger, S, Porro, A, Dusi, A, Corsini, P, Zane, M, Trebeschi, M, Sposetti, P, Fabbri, A, David, C, Giuliano, L, Dusi, P, Benedetti, C, Nichilo, V, Boroni, C, Balboni, M, Vanni, D, Vanni, P, Cipolla,C, Corsini,P, Boroni, Carla, and Boroni, Carla (ORCID:0000-0003-0549-3361)

Abstract

La natura letteraria dei testi coevi o di poco successivi agli eventi della Seconda Guerra d’Indipendenza, in particolare dei testi che fanno riferimento all’assistenza dei feriti, è praticamente nulla. L’argomento non si prestava in termini di descrizione e infatti figura quasi esclusivamente a compendio della descrizione della battaglia e delle sue conseguenze. Le poche righe scritte in proposito si soffermano sull’aspetto patetico della condizione dei feriti, o sugli aspetti organizzativi, logistici e statistici, dell’assistenza. Le annotazioni letterarie sono giusto annotazioni legate alla contingenza dell’evento e quelle che si spingono un poco oltre, cercando di umanizzare i numeri e di individualizzare l’esperienza dei feriti, lo fanno come di sfuggita e senza pretendere di fare della letteratura vera e propria. Quando lo fanno, o cercano di farlo, cadono nella retorica facendo ricorso alla frase che inneggia, che vuole celebrare e spesso commuovere, ma sempre in modo oleografico, convenzionale e stereotipato. La cronaca può far parte della letteratura, ma non è, di per sé, letteratura, se non in senso lato. Si usa chiamare letteratura ogni cosa scritta intorno a un argomento, ma non è, ovviamente, a questo tipo di letteratura che qui si intende fare riferimento. La letteratura intesa come pratica letteraria condotta all’interno di una tradizione, sia linguistica che culturale, si dimostra piuttosto latitante nei confronti delle imprese risorgimentali, ancor più nei confronti di argomenti considerati a margine di tali imprese.

Published
2017

68. Rassegna bibliografica

Author

Graifenberg, A., Graifemberg, A., Gregorini, G., and Pisani, P. L.

Published
1973

75. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group

Author

Jayne, D, Rasmussen, N, Abramowicz, D, Tesar, V, Petersen, J, Juhl, B, Wiik, A, Gronhagenriska, C, Guillevin, L, Lhote, F, Landais, P, Lesavre, P, Vanhille, P, Andrassy, K, Degroot, K, Gross, W, Vanderwoude, F, Boki, K, Tervaert, J, Kallenberg, C, Vanes, L, Hermans, J, Siegert, C, Hagen, E, Feighery, C, Gregorini, G, Ferrario, F, Dadoniene, J, Vasconcelos, C, Mirapeix, E, Heigl, Z, Pettersson, E, Westman, K, Bacon, P, Savage, C, Lockwood, C, Luqmani, R, Gaskin, G, Pusey, C, Specks, U., SINICO, RENATO ALBERTO, Jayne, D, Rasmussen, N, Abramowicz, D, Tesar, V, Petersen, J, Juhl, B, Wiik, A, Gronhagenriska, C, Guillevin, L, Lhote, F, Landais, P, Lesavre, P, Vanhille, P, Andrassy, K, Degroot, K, Gross, W, Vanderwoude, F, Boki, K, Tervaert, J, Kallenberg, C, Vanes, L, Hermans, J, Siegert, C, Hagen, E, Feighery, C, Gregorini, G, Ferrario, F, Sinico, R, Dadoniene, J, Vasconcelos, C, Mirapeix, E, Heigl, Z, Pettersson, E, Westman, K, Bacon, P, Savage, C, Lockwood, C, Luqmani, R, Gaskin, G, Pusey, C, and Specks, U

Subjects
Vasculitis, medicine.medical_specialty, International Cooperation, PLASMA-EXCHANGE, Birmingham Vasculitis Activity Score, PULSE CYCLOPHOSPHAMIDE, DISEASE-ACTIVITY, Methylprednisolone, Severity of Illness Index, Drug Administration Schedule, Antibodies, Antineutrophil Cytoplasmic, law.invention, Randomized controlled trial, Adrenal Cortex Hormones, law, Azathioprine, Necrotizing Vasculitis, medicine, Humans, Intensive care medicine, Cyclophosphamide, Anti-neutrophil cytoplasmic antibody, Clinical Trials as Topic, business.industry, NECROTIZING VASCULITIS, General Medicine, medicine.disease, Europe, Clinical trial, POLYARTERITIS, Methotrexate, Immunology, IMMUNOGLOBULIN, INTRAVENOUS GAMMA-GLOBULIN, MICROSCOPIC, WEGENERS GRANULOMATOSIS, Microscopic polyangiitis, business, RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS, Immunosuppressive Agents, CYCLOPHOSPHAMIDE THERAPY, Systemic vasculitis
Abstract

The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by extent and severity of disease, and ''standard'' and ''best alternative'' therapeutic regimens. Two series of randomized controlled trials have been designed; their aims are (1) to harmonize current approaches to treatment and (2) to test the value of newer therapeutic agents, In support of these trials, semiobjective scoring systems have been created and validated, and previous standardization of ANCA serologic and histologic analysis has been adopted. The systems of classification and clinical management described herein represent the recommendations of a multidisciplinary study group that hopes to improve the outcome of patients with primary systemic vasculitis by wide dissemination of the collective experience from interested centers.

Published
1997

76. Association of a TNFSF13B (BAFF) Regulatory Region Single Nucleotide Polymorphisms with Response to Rituximab in Anca-Associated Vasculitis

Author

Alberici, F, Smith, R, Fonseca, M, Willcocks, L, Jones, R, Holle, J, Wieczorek, S, Neumann, T, Martorana, D, Gregorini, G, Sinico, R, Bruchfeld, A, Gunnarsson, I, Ohlsson, S, Baslund, B, Tesar, V, Hruskova, Z, Cid, M, Vaglio, A, Lyons, P, Smith, K, Jayne, D, Jayne, D., SINICO, RENATO ALBERTO, Alberici, F, Smith, R, Fonseca, M, Willcocks, L, Jones, R, Holle, J, Wieczorek, S, Neumann, T, Martorana, D, Gregorini, G, Sinico, R, Bruchfeld, A, Gunnarsson, I, Ohlsson, S, Baslund, B, Tesar, V, Hruskova, Z, Cid, M, Vaglio, A, Lyons, P, Smith, K, Jayne, D, Jayne, D., and SINICO, RENATO ALBERTO

Published
2016

77. Characterization of MPO-ANCA reactivity in patients with Churg-Strauss syndrome (CSS)

Author

Radice, A, Bianchi, L, Bredi, E, Maggiore, U, Gregorini, G, Ikehata, M, Wieslander, J, Farina, L, Romelli, P, SINICO, RENATO ALBERTO, Radice, A, Bianchi, L, Bredi, E, Maggiore, U, Gregorini, G, Ikehata, M, Wieslander, J, Farina, L, Romelli, P, and Sinico, R

Subjects
ANCA, anti-MPO, Churg-Strauss syndrome, epitope
Published
2009

78. HLA-DRB4*01: A risk factor for the development of Churg-Strauss syndrome

Author

Vaglio, A, Martorana, D, Garini, G, Grasselli, C, Casazza, I, Manenti, L, Ferretti, S, Gregorini, G, Neri, T, Buzio, C., SINICO, RENATO ALBERTO, Vaglio, A, Martorana, D, Garini, G, Grasselli, C, Casazza, I, Manenti, L, Ferretti, S, Sinico, R, Gregorini, G, Neri, T, and Buzio, C

Subjects
Churg-Strauss syndrome, HLA, ANCA
Published
2006

79. Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy

Author

Cabiddu, G, Castellino, S, Gernone, G, Santoro, D, Giacchino, F, Credendino, O, Daidone, G, Gregorini, G, Moroni, G, Attini, R, Minelli, F, Manisco, G, Todros, T, Piccoli, G, Pieruzzi, F, Pieruzzi, FUEG, Cabiddu, G, Castellino, S, Gernone, G, Santoro, D, Giacchino, F, Credendino, O, Daidone, G, Gregorini, G, Moroni, G, Attini, R, Minelli, F, Manisco, G, Todros, T, Piccoli, G, Pieruzzi, F, and Pieruzzi, FUEG

Abstract

Background: Pregnancy during dialysis is increasingly being reported and represents a debated point in Nephrology. The small number of cases available in the literature makes evidence-based counselling difficult, also given the cultural sensitivity of this issue. Hence, the need for position statements to highlight the state of the art and propose the unresolved issues for general discussion. Methods: A systematic analysis of the literature (MESH, Emtree and free terms on pregnancy and dialysis) was conducted and expert opinions examined (Study Group on Kidney and Pregnancy; experts involved in the management of pregnancy in dialysis in Italy 2000–2013). Questions regarded: timing of dialysis start in pregnancy; mode of treatment, i.e. peritoneal dialysis (PD) versus haemodialysis (HD); treatment schedules (for both modes); obstetric surveillance; main support therapies (anaemia, calcium-phosphate parathormone; acidosis); counselling tips. Main results: Timing of dialysis start is not clear, considering also the different support therapies; successful pregnancy is possible in both PD and HD; high efficiency and strict integration with residual kidney function are pivotal in both treatments, the blood urea nitrogen test being perhaps a useful marker in this context. To date, long-hour HD has provided the best results. Strict, personalized obstetric surveillance is warranted; therapies should be aimed at avoiding vitamin B12, folate and iron deficits, and at correcting anaemia; vitamin D and calcium administration is safe and recommended. Women on dialysis should be advised that pregnancy is possible, albeit rare, with both types of dialysis treatment, and that a success rate of over 75 % may be achieved. High dialysis efficiency and frequent controls are needed to optimize outcomes.

Published
2015

81. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity

Author

Rasmussen, N., Salmela, A., Ekstrand, A., de Groot, K., Gregorini, G., Tervaert, J. W. Cohen, Gross, W. L., Wiik, A., Jayne, D. R. W., RS: CARIM School for Cardiovascular Diseases, and RS: MHeNs School for Mental Health and Neuroscience

Subjects
granulomatosis with polyangiitis (Wegener's), antineutrophil cytoplasmic autoantibodies, ELISA, Wegener's granulomatosis, disease activity
Abstract

Objective. To investigate the nature of the relationship between proteinase 3 anti-neutrophil cytoplasm autoantibody (PR3-ANCA) and relapse in patients with early systemic granulomatosis with polyangiitis (Wegener's) (GPA).Methods. Clinical data from 16 relapsing and 12 non-relapsing patients with early systemic GPA from a randomised clinical trial were correlated to monthly PR3-ANCA values over 18 months. Each sample was examined using 9 different enzyme-linked immunosorbent assays (ELISAs) to ensure reliability of ANCA results. PR3-ANCA peaks were identified by the highest sum of logarithmic transformation values from all assays in samples after remission.Results. A PR3-ANCA peak was identified in all relapsing and non-relapsing patients and coincided with relapse in all 14 evaluable relapsing patients. The monthly increment before the peak, however, was similar in relapsing and non-relapsing patients in all assays. Increments from remission to peak were higher in relapsing patients in 219 assays. PR3-ANCA values at entry and peak PR3-ANCA values were higher in relapsing patients in 319 and 219 assays, respectively. However, large overlaps of PR3-ANCA values prevented a distinction between relapsing and non-relapsing patients. The median time to reach peak values was 14 months in relapsing and 12 months in non-relapsing patients with scheduled termination of treatment at 12 months.Conclusion. The predictive value for relapses of PR3-ANCA determinations confirm and extend previous reports. Although all relapses were related to PR3-ANCA increases, reduction or withdrawal of immunosuppression without relapse was also related to increases and may explain the lack of predictive value of sequential PR3-ANCA determinations.

Published
2013

82. Clinical nephrology-epidemiology-clinical trials: Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients

Author

Hauer, Herbert A., Bajema, Ingeborg M., Van Houwelingen, Hans C., Ferrario, Franco, Noã«l, Laure Hélène, Waldherr, Rã¼diger, Jayne, David R. W., Rasmussen, Niels, Bruijn, Jan A., Hagen, E. Christiaan, Rasmussen, N., Jayne, D. R. W., Neumann, I., Mad Houn, P., Sennesael, J., Tesar, V., Rychlik, I., Bartunkova, J., Luk, J., Juhl, B. Ravn, Petersen, J., Andersen, C. B., Szpirt, W., Wiik, A., Lokkegaard, H., Nielsen, H., Ring, T., Sorensen, S. Freiesleben, Bacon, P. A., Exley, A., Savage, C. O. S., Gaskin, G., Pusey, C., Lockwood, C. M., Luq Mani, R., Gronhagen Riska, C., Ekstrand, A., Guillevin, L., Lhote, F., Lesavre, P., Noel, L. H., Landais, P., Vanhille, P., Bataille, P., Esnault, V., Woude, F. Van Der, Waldherr, R., Schmitt, W., Andrassy, K., Hergesell, O., Nowack, R., Groot, K. De, Herlyn, K., Gross, W. L., Boki, K. A., Boletis, J. N., Emmanouel, D. S., Feighery, C., Ferra Rio, Y., Sinico, R. A., Gregorini, G., Dadoniene, J., Hagen, E. C., Kallenberg, C. G. M., Stegeman, C., Tervaert, J. W. Cohen, Verburgh, C. A., Siegert, C. E. H., Bruijn, J. A., Hauer, H. A., Hermans, J., Houwelingen, J. C. Van, Vergunst, C. E., Gurp, E. Van, Bajema, I. M., Vasconcelos, C., Mirapeix, E., Sole, M., Petterson, E. E., Bruchfeld, A., Westman, K. W. A., Heigl, Z., Chizzolini, C., Maclahan, D., Depierreux, M., van Damme, B., Stejskalova, A., Vernerova, Z., Tornroth, T., Feller, A. C., Gaffney, E., Tardanico, R., Consalonieri, R., Garibotto, Giacomo, Tiebosch, A. T. M. G., Kooijman, C. D., Arques, M. S., Algaba, F., Carreras, M., Perez, M. Vaquero, Bernardo, L., Sundelin, B., Alm, P., Wernersson, A., Veress, B., Landells, W., Howie, A. J., Fleming, S., Griffith, A. P., Furness, P. N., Cook, H. T., Hauer, H, Bajema, I, Van Houwelingen, H, Ferrario, F, Noël, L, Waldherr, R, Jayne, D, Rasmussen, N, Bruijn, J, Hagen, E, Neumann, I, Mad Houn, P, Sennesael, J, Tesar, V, Rychlik, I, Bartunkova, J, Luk, J, Juhl, B, Petersen, J, Andersen, C, Szpirt, W, Wiik, A, Lokkegaard, H, Nielsen, H, Ring, T, Sorensen, S, Bacon, P, Exley, A, Savage, C, Gaskin, G, Pusey, C, Lockwood, C, Luq Mani, R, Gronhagen Riska, C, Ekstrand, A, Guillevin, L, Lhote, F, Lesavre, P, Noel, L, Landais, P, Vanhille, P, Bataille, P, Esnault, V, Woude, F, Schmitt, W, Andrassy, K, Hergesell, O, Nowack, R, Groot, K, Herlyn, K, Gross, W, Boki, K, Boletis, J, Emmanouel, D, Feighery, C, Ferra Rio, Y, Sinico, R, Gregorini, G, Dadoniene, J, Kallenberg, C, Stegeman, C, Tervaert, J, Verburgh, C, Siegert, C, Hermans, J, Houwelingen, J, Vergunst, C, Gurp, E, Vasconcelos, C, Mirapeix, E, Sole, M, Petterson, E, Bruchfeld, A, Westman, K, Heigl, Z, Chizzolini, C, Maclahan, D, Depierreux, M, van Damme, B, Stejskalova, A, Vernerova, Z, Tornroth, T, Feller, A, Gaffney, E, Tardanico, R, Consalonieri, R, Garibotto, G, Tiebosch, A, Kooijman, C, Arques, M, Algaba, F, Carreras, M, Perez, M, Bernardo, L, Sundelin, B, Alm, P, Wernersson, A, Veress, B, Landells, W, Howie, A, Fleming, S, Griffith, A, Furness, P, and Cook, H

Subjects
Prognosi, Biopsy, Antineutrophil Cytoplasmic, Predictive Value of Test, Antibodies, Antibodies, Antineutrophil Cytoplasmic, Immunosuppressive Agent, Glomerulonephritis, Predictive Value of Tests, Recurrence, Azathioprine, Humans, Prospective Studies, Microscopic polyangiiti, Glomerulonephriti, Microscopic polyangiitis, Cyclophosphamide, Pauci-immune crescentic necrotizing glomerulonephritis, Medicine (all), Granulomatosis with Polyangiitis, Prognosis, Wegener's granulomatosis, ANCA-associated vasculiti, Prospective Studie, Treatment Outcome, ANCA-associated vasculitis, Renal biopsy, Glomerular Filtration Rate, Immunosuppressive Agents, Sample Size, Nephrology, Wegener's granulomatosi, Pauci-immune crescentic necrotizing glomerulonephriti, Granulomatosis with Polyangiiti, Human
Abstract

Background. The predictive value of clinical and renal histological features for renal outcome in patients with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis was investigated in a prospective analysis of 96 patients with ANCA-associated vasculitis, and moderate renal involvement (creatinine

Published
2002

84. Cocaine, ANCA, and Wegener's granulomatosis

Author

Ml, Morassi, Matteo Trimarchi, Nicolai P, Gregorini G, Maroldi R, Specks U, Facchetti F, Morassi, Ml, Trimarchi, Matteo, Nicolai, P, Gregorini, G, Maroldi, R, Specks, U, and Facchetti, F.

Published
2001

92. PREGNANCY AND PROGRESSION OF IGA NEPHROPATHY: RESULTS OF AN ITALIAN MULTICENTER STUDY

Author

Limardo, M, Imbasciati, E, Ravani, P, Surian, M, Torres, D, Gregorini, G, Magistroni, R, Casellato, D, Gammaro, L, Pozzi, C, Gammaro L, Rene e. Gravidanza Collaborative Group of the Italian Society of N. e. p. h. r. o. l. o. g. y., Beati, S, Ambroso, G, Maggio, M, Del Giudice, A, De Cristofaro, V, Gallo, E, Gernone, G, Marega, A, Rustichelli, R, Cabiddu, G, Rollino, C, Fanciulli, E, Feriozzi, S, Pecchini, P, Bizzarri, D, D'Amico, M, Proietti, E, Baratelli, L, Battista Reinero, G, Garibotto, Giacomo, Rocchietti, M, Allegri, L, Dugo, M, Cirami, L, Esposito, C, Amico, L, Mariani, P, Baroli, A, Giannattasio, M, Stratta, P, Montanaro, D, Gesualdo, L, Daidone, G, Manfellotto, D, and Castellino, S.

Published
2010

95. PULSE VERSUS DAILY ORAL CYCLOPHOSPHAMIDE FOR INDUCTION OF REMISSION IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS: A RANDOMIZED TRIAL

Author

de Groot, K, Harper, L, Jayne, Dr, Flores Suarez LF, Gregorini, G, Gross, Wl, Luqmani, R, Pusey, Cd, Rasmussen, N, Sinico, Ra, Tesar, V, Vanhille, P, Westman, K, Savage, Co, EUVAS Collaborators Abramowicz, D, Wissing, M, Madhoun, P, Blockmans, D, Stolear, J, Ekstrand, A, Chabova, V, Teasr, V, Rychlik, I, Bataille, P, Puechal, X, Leblau, J, Esnault, Vl, Weidner, S, Rupprecht, H, Schneider, M, Specker, C, Schmitt, W, van der Woude, F, Vischedyck, M, Feighery, C, Garibotto, Giacomo, Santostefano, M, Dadoniene, J, Flores Suarez, L, Hagen, Ec, Oudejans, I, Verburgh, C, Ballarin, J, Mirapeix, E, Valles, M, Bruchfeld, A, Pettersson, E, Eriksson, P, Selga, D, Segelmark, M, Lundberg, I, Svenungsson, E, Chizzolini, C, Adu, D, Savage, C, de Souza, R, and Watts, R.

Published
2009

97. Severe palatal necrosis in cocaine abusers

Author

Gregorini G, Majorana A, Facchetti F, Morassi ML, Gigola P, Sapelli PL, TRIMARCHI , MATTEO, Gregorini, G, Majorana, A, Facchetti, F, Morassi, Ml, Gigola, P, Trimarchi, Matteo, and Sapelli, Pl

Published
1998

99. Antiendothelial cell antibodies: A diagnostic and prognostic tool in Wegener's granulomatosis and micropolyarteritis?

Author

Delpapa, N, Farsi, A, Guidali, L, Raschi, E, Domeneghetti, M, Azzurri, A, Radice, A, Moroni, G, Ponticelli, C, Emmi, L, Tincani, A, Gregorini, G, Passaleva, A, Meroni, P., SINICO, RENATO ALBERTO, Delpapa, N, Farsi, A, Guidali, L, Raschi, E, Domeneghetti, M, Azzurri, A, Radice, A, Sinico, R, Moroni, G, Ponticelli, C, Emmi, L, Tincani, A, Gregorini, G, Passaleva, A, and Meroni, P

Subjects
Vasculitis, anti-endothelial cell antibodies
Published
1997

Catalog

Books, media, physical & digital resources
See catalog results